Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday June 10, 2025 — 04:35 pm EDT Written by Eric Volkman for The Motley Fool -> ...

Recursion Pharmaceuticals jumped by 31.3 percent week-on-week following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding affinity.

Recently, two leading and long-established firms in the expanding AI drug discovery sector revealed an unexpected merger. In an approximate 75-25 agreement, Recursion Bio and Exscientia are set to ...

UPS is a turnaround with a 6.7% yield and a price that's just at the cusp of $100. Brookfield Renewable Partners has a 6.5% yield and a long runway for growth. Enterprise Products Partners offers ...

Investors in Recursion Pharmaceuticals Inc (Symbol: RXRX) saw new options begin trading today, for the July 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million Skip to main content Tuesday 24 June 2025 . BlueSky ...

Best high-yield checking accounts of July 2025: Earn up to 5.15% APY If you want to maximize that money sitting in your checking account, these accounts are for you. Updated Wed, Jun 25 2025.